Harm reduction in hospitals

Malika Sharma^{1

2}, Wiplove Lamba³, Alexander Cauderella³, Timothy H Guimond^{4

5}, Ahmed M Bayoumi^{6

7

8

9}

Affiliations

¹ Maple Leaf Medical Clinic, Toronto, ON, Canada. malika.sharma@mail.utoronto.ca.
² Division of Infectious Diseases, St. Michael's Hospital, Toronto, ON, Canada. malika.sharma@mail.utoronto.ca.
³ Mental Health and Addictions service, St. Michael's Hospital, Toronto, Ontario, Canada.
⁴ Centre for Addiction and Mental Health, Toronto, ON, Canada.
⁵ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁶ Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
⁹ Division of General Internal Medicine, St. Michael's Hospital, Toronto, ON, Canada.

Malika Sharma et al. Harm Reduct J. 2017.

. 2017 Jun 5;14(1):32.

doi: 10.1186/s12954-017-0163-0.

Malika Sharma^{1

2}, Wiplove Lamba³, Alexander Cauderella³, Timothy H Guimond^{4

5}, Ahmed M Bayoumi^{6

7

8

9}

¹ Maple Leaf Medical Clinic, Toronto, ON, Canada. malika.sharma@mail.utoronto.ca.
² Division of Infectious Diseases, St. Michael's Hospital, Toronto, ON, Canada. malika.sharma@mail.utoronto.ca.
³ Mental Health and Addictions service, St. Michael's Hospital, Toronto, Ontario, Canada.
⁴ Centre for Addiction and Mental Health, Toronto, ON, Canada.
⁵ Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
⁶ Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.
⁷ Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁸ Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada.
⁹ Division of General Internal Medicine, St. Michael's Hospital, Toronto, ON, Canada.

No abstract available

Keywords: Harm reduction; Hospital; Medication-assisted therapy; Opioid-related disorders; People who use drugs; Substance misuse.

References

1. Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. Lancet Lond Engl. 2009;374:1284–93. doi: 10.1016/S0140-6736(09)61036-9. - DOI - PubMed
1. Fisher ES, Shortell SM, Savitz LA. Implementation science: a potential catalyst for delivery system reform. JAMA. 2016;315:339–40. doi: 10.1001/jama.2015.17949. - DOI - PMC - PubMed
1. Broyles LM, Binswanger IA, Jenkins JA, Finnell DS, Faseru B, Cavaiola A, et al. Confronting inadvertent stigma and pejorative language in addiction scholarship: a recognition and response. Subst Abuse. 2014;35:217–21. doi: 10.1080/08897077.2014.930372. - DOI - PMC - PubMed
1. Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174:1369–76. doi: 10.1001/jamainternmed.2014.2556. - DOI - PMC - PubMed
1. Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry J Ment Sci. 2015;207:5–14. doi: 10.1192/bjp.bp.114.149195. - DOI - PubMed